Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Longitudinal utilization of systemic immunomodulators before and after dupilumab approval in children with atopic dermatitis

Pediatric Dermatology(2022)10.1111/pde.15172Source: DataRank Database

Longitudinal utilization of systemic immunomodulators before and after dupilumab approval in children with atopic dermatitis is a research paper published in Pediatric Dermatology (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.62)OA: greenTopics (25)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Sebastian Schneeweiß ORCID,Arash Mostaghimi ORCID,Maria C. Schneeweiss ORCID,Priyanka Anand ORCID

Live enrichment

PubMed:36403606 PMC:PMC9868069 OpenAlex:https://openalex.org/W4309512956

National Institutes of Health

Grant: R01 AR080194

FWCI

0.62

Citation Percentile

0.7%

Citation Trend

2024

2025

greenLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9868069

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/pde.15172

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1111/pde.15172

journalhttps://doi.org/10.1111/pde.15172

Fields of Study

Dermatology and Skin DiseasesAsthma and respiratory diseasesAllergic Rhinitis and Sensitization

MeSH Terms

Adjuvants, ImmunologicChildDermatitis, AtopicHumansImmunologic FactorsCohort StudiesTreatment OutcomeAntibodies, Monoclonal, Humanized

Keywords

DupilumabMedicineAtopic dermatitisDermatologyAzathioprineCohortMethotrexateInternal medicineDiseaseUtilizationcyclosporineepidemiologyMycophenolateImmunomodulating Drugs

Sustainable Development Goals

SDG 0: Good health and well-being